2024-10-09 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM), and healthcare services businesses.

**Performance Analysis:**

**1. Performance Relative to S&P 500 (VOO):**

* **Cumulative Return:** CVS: -30.2%, VOO: 133.14%
* **Performance Gap:** -163.34 (Current), 9.31 (Max), -163.34 (Min)
* **Relative Performance:** 2.39 (This means CVS is currently performing at the 2.39 percentile of its historical performance relative to VOO)

**2. Recent Price Movement:**

* **Closing Price:** $64.59
* **5-day Moving Average:** $62.83
* **20-day Moving Average:** $59.22
* **60-day Moving Average:** $58.76

**3. Technical Indicators:**

* **RSI:** 75.7 (Indicates an overbought condition)
* **PPO:** 1.07 (Positive value suggests potential upside momentum)
* **Delta_Previous_Relative_Divergence:** -4.78 (Indicates a recent short-term downward trend)
* **Expected Return:** 0.0% (This represents the expected return over the next five years, exceeding the return of the S&P 500)

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

* CVS's most recent earnings release (2024-08-07) exceeded analysts' expectations, reporting EPS of 1.83 compared to the expected 1.73. This indicates a positive outlook for the company's performance. 

**5. News and Recent Issues:**

* **Recent Market Outlook:** The market outlook for CVS remains generally positive, with analysts citing its strong earnings performance and growing healthcare services segment as key drivers.  
* **Analyst Opinions:**  Analysts have a consensus "Hold" rating for CVS, with a target price of $75. This indicates potential for upside growth from its current price.
* **Performance Highlights:** CVS has faced challenges from inflation and rising healthcare costs, but it has remained competitive and is showing signs of growth in its core business.

**6. Overall Analysis:**

* CVS is currently trading at an overbought level, with a high RSI value.
* Despite strong recent earnings and a positive market outlook, the stock has significantly underperformed the S&P 500 in the long term.
* However, its strong earnings performance and continued growth in the healthcare services segment suggest potential for future growth.
* Investors should carefully consider the current market conditions and the risks associated with CVS before making any investment decisions.

**7. Conclusion:**

While CVS has shown positive recent performance, its long-term underperformance relative to the market raises concerns. The stock's high RSI value indicates an overbought condition, which might lead to a correction. Despite these risks, CVS's growth potential in the healthcare services segment and recent earnings outperformance warrant further observation. Investors should stay informed about the company's future performance and market trends before making any investment decisions.
